• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Practical Matters: Difficulties in diagnosing transitional cell carcinoma

October 1, 2006
Linda Fineman, DVM, DACVIM (oncology)

Diagnosing transitional cell carcinoma can be a difficult clinical challenge. Clinical signs (pollakiuria, dysuria, stranguria, and hematuria) are nonspecific, and differential diagnoses include granulomatous cystitis, other neoplastic diseases (lymphoma, rhabdomyosarcoma), a persistent or recurrent urinary tract infection, and urinary calculi-the latter two of which may occur concurrently with transitional cell carcinoma.

Diagnosing transitional cell carcinoma can be a difficult clinical challenge. Clinical signs (pollakiuria, dysuria, stranguria, and hematuria) are nonspecific, and differential diagnoses include granulomatous cystitis, other neoplastic diseases (lymphoma, rhabdomyosarcoma), a persistent or recurrent urinary tract infection, and urinary calculi—the latter two of which may occur concurrently with transitional cell carcinoma.

Linda Fineman

A urinalysis may reveal abnormal epithelial cells, but in the face of inflammation, transitional cells may be reactive, and distinguishing reactive cells from neoplastic cells can be difficult, even for an experienced clinical pathologist. While many clinicians use the veterinary bladder tumor antigen (V-BTA—Polymedco) urine test to confirm transitional cell carcinoma, false positive results may occur when pyuria (> 30 WBC/HPF), hematuria (> 30 RBC/HPF), proteinuria (4+), or glucosuria (4+) is present. Since this test has an overall sensitivity of 90% and an overall specificity of 78% for diagnosing transitional cell carcinoma, it may be more useful in routine screenings of at-risk populations (e.g. Scottish terriers, West Highland white terriers, Shetland sheepdogs, beagles, geriatric patients) in the absence of urinary tract signs.

Advertisement

An ultrasonographic examination of the urinary tract may reveal a mass in the trigone or adjacent urethra, providing suggestive, but not definitive, evidence of transitional cell carcinoma.

Although somewhat controversial, I do not perform ultrasound-guided fine-needle aspiration biopsy in patients with suspected transitional cell carcinoma because of concerns about seeding the needle tract with neoplastic cells. Transitional cell carcinoma is thought to be easily transplantable, so samples should be obtained by way of the urinary tract. I prefer to use either traumatic catheterization or cystoscopy-guided biopsy to obtain diagnostic samples. While samples obtained via cystoscopy are small, there is a classic gross appearance (friable, white fimbriated tissue), which can provide further indirect support for the histologic diagnosis.

Linda Fineman, DVM, DACVIM (oncology)

Veterinary Medical Specialists

907 Dell Avenue Campbell, CA 95008

Related Content:

Oncology
Study finds certain canine breeds should be screened for cancer at young ages
Study finds certain canine breeds should be screened for cancer at young ages
New clinical foods launched to support cats and dogs with cancer
New clinical foods launched to support cats and dogs with cancer
Study reveals OncoK9 liquid biopsy test can enhance cancer monitoring in canines
Study reveals OncoK9 liquid biopsy test can enhance cancer monitoring in canines

Advertisement

Latest News

Pet safety for this Super Bowl Sunday

New video series informs pet owners on dog and cat nutrition

3 Must-reads for National Pet Dental Health Month

Veterinary Dentistry Specialists first to apply human fracture repair technology to companion animals

View More Latest News
Advertisement